Position in ARVN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$37,810
-$10,420 QoQ
Shares Held
4,550
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#149
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ameritas Investment Partners, Inc. holds $62,741,652 across 267 Biotechnology names. ARVN ranks #165 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,422 | $6,170,379 | |
| 2 | EXEL |
Exelixis, Inc.
|
75,969 | $4,133,473 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
40,729 | $3,187,858 | |
| 4 | CYTK |
Cytokinetics Inc
|
36,992 | $3,151,348 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
83,064 | $2,939,634 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,593 | $2,863,919 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
11,547 | $2,782,480 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
25,923 | $2,112,983 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,810 | 4,550 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $48,230 | 4,550 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $65,633 | 5,534 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $53,624 | 6,294 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $46,323 | 6,294 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $44,183 | 6,294 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $120,655 | 6,294 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $155,021 | 6,294 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $167,546 | 6,294 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $201,405 | 4,879 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $200,819 | 4,879 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $95,823 | 4,879 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $96,599 | 3,892 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $106,329 | 3,892 | Shares | Other | 2023-05-10 | |
| 2022-12-31 | $133,145 | 3,892 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $161,988 | 3,641 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $153,249 | 3,641 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $245,039 | 3,641 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $299,071 | 3,641 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $281,219 | 3,422 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $263,494 | 3,422 | Shares | Other | 2021-08-06 | |
| 2021-03-31 | $197,242 | 2,984 | Shares | Other | 2021-05-14 | |
| 2020-12-31 | $253,431 | 2,984 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $61,008 | 2,584 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $86,667 | 2,584 | Shares | Other | 2020-08-05 | |
| 2020-03-31 | $73,386 | 1,821 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||